Skip to content
CNS Clinical Research

Oregon

CNS clinical trials in Oregon

58 CNS studies are recruiting participants at sites in 12 cities across Oregon as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Oregon city with a recruiting study

By research area: Parkinson's Disease (21), Depression (14), Migraine (7), ADHD (6), Epilepsy (5), Multiple Sclerosis (3), Schizophrenia (2).

Portland (47), Eugene (5), Corvallis (2), Springfield (2), Tigard (2), Bend (1), Gresham (1), Hood River (1), Newberg (1), Oregon City (1), Redmond (1), Salem (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Oregon

Basic details from each study's public record (the 12 most recently updated of 58). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Mechanisms of Depression and Anhedonia in Adolescents: Linking Sleep to Reward- and Stress-Related Brain Function

    • No phase
    • Ages 14 to 18
    • All sexes
    Sponsor
    University of Oregon
    Recruiting in
    Eugene
    Registry record
    NCT05691439 · updated
  2. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Portland
    Registry record
    NCT07226661 · updated
  3. Center M Randomized Trial

    • No phase
    • Ages 18 and older
    • Female participants
    Sponsor
    Oregon Health and Science University
    Recruiting in
    Portland
    Registry record
    NCT07304895 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Oregon on ClinicalTrials.gov.

Schizophrenia: recently updated in Oregon

  1. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    MapLight Therapeutics
    Recruiting in
    Tigard
    Registry record
    NCT06887192 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Oregon on ClinicalTrials.gov.

Parkinson's disease: recently updated in Oregon

  1. DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    AstraZeneca
    Recruiting in
    Eugene
    Registry record
    NCT06989112 · updated
  2. A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Eugene
    Registry record
    NCT06952504 · updated
  3. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Tigard
    Registry record
    NCT06966700 · updated
  4. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Corvallis
    Registry record
    NCT06623422 · updated
  5. An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Yale University
    Recruiting in
    Portland
    Registry record
    NCT06996652 · updated
  6. A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Eugene
    Registry record
    NCT07216703 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Oregon on ClinicalTrials.gov.

Epilepsy: recently updated in Oregon

  1. Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

    • Phase 4
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Portland
    Registry record
    NCT04419272 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Oregon on ClinicalTrials.gov.

Migraine: recently updated in Oregon

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Recruiting in
    Portland
    Registry record
    NCT06972056 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Oregon on ClinicalTrials.gov.

Ask about studies in Oregon

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call